RNS Number : 6913M Harwood Capital LLP 30 April 2024 FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS) Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code") 1. KEY
RNS Number : 6762M Harwood Capital LLP 30 April 2024 AMENDMENT: THIS FORM REPLACES RNS NUMBER 9333G, ANNOUNCED ON 14 MARCH 2024 AT 15:38. CHANGE MADE TO SECTION 2b. AMENDMENT: PLEASE DISREGARD THE RNS RELEASED ON 15 MARCH 2024 AT 12:05, RNS NUMBER 0829H, FORM 8 (DD) PUBLIC DEALING
RNS Number : 4878M Renalytix PLC 30 April 2024 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing
RNS Number : 4647M Renalytix PLC 29 April 2024 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Icahn
RNS Number : 3854M Stifel Nicolaus Europe Limited 29 April 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name
RNS Number : 2850M Renalytix PLC 29 April 2024 Renalytix plc ("Renalytix" or the "Company") Admission of the First Tranche Placing Shares LONDON and SALT LAKE CITY - 29 April 2024 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) confirms that, further to the announcements made on 12 March
RNS Number : 2943M Renalytix PLC 26 April 2024 S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares: Renalytix PLC 1b. Please indicate if the issuer is a non- UK issuer (please mark with an "X"
RNS Number : 2828M Lombard Odier Asset Mgt (Eur) Ltd. 26 April 2024 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of
RNS Number : 2815M Renalytix PLC 26 April 2024 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing
RNS Number : 2067M Stifel Nicolaus Europe Limited 26 April 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name